Aerogen and CanSinoBIO partner for inhaled COVID-19 vaccine delivery

Aerogen and CanSinoBIO announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO's Convidecia COVID-19 vaccine using Aerogen's vibrating mesh nebulizer technology.

“Aerogen and CanSinoBIO agree landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery”businesswire.com

• 1 source
• businesswire.comAerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine deliveryDec 9, 2021

Summarized from public sources; check the original articles before acting on it.